Change in myasthenia gravis epidemiology in Trento, Italy, after twenty years

Neuroepidemiology

Volumn 36, Issue 4, 2011, Pages 282-287

  Pallaver, Fabrizio ^a   Riviera, Anna Pia ^d   Piffer, Silvano ^b   Ricciardi, Roberta ^e   Roni, Riccardo ^c   Orrico, Daniele ^a   Bonifati, Domenico Marco ^a  

^a SANTA CHIARA HOSPITAL   (Italy)

^b Azienda Provinciale Servizi Sanitari   (Italy)

^c Pharmaceutical Service   (Italy)

^d UNIVERSITY OF VERONA   (Italy)

^e UNIVERSITY OF PISA   (Italy)

Author keywords

Myasthenia gravis incidence; Trento, Italy

Indexed keywords

CHOLINESTERASE INHIBITOR;

ADOLESCENT; ADULT; ANTIBODY SCREENING; ARTICLE; FEMALE; HUMAN; IMMUNOASSAY; ITALY; MAJOR CLINICAL STUDY; MALE; MORALITY; MORBIDITY; MYASTHENIA GRAVIS; ONSET AGE; PREVALENCE;

ADULT; AGE DISTRIBUTION; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; ITALY; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; PREVALENCE; SEX DISTRIBUTION; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 79960262243     PISSN: 02515350     EISSN: 14230208     Source Type: Journal    
DOI: 10.1159/000328863     Document Type: Article

References (20)

1. Vincent A, Palace J, Hilton-Jones D: Myas-thenia gravis. Lancet 2001; 357:2122-2128.
2. Meriggioli MN, Sanders DB: Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol 2009; 8:475-901.
3. Carr AS, Cardwell CR, McCarron PO, Mc-Conv il le J: A systematic rev iew of population based epidemiological studies in myasthenia gravis. BMC Neurol 2010; 10:46.
4. McGrogan A, Sneddon S, de Vries CS: The incidence of myasthenia gravis: a systematic literature review. Neuroepidemiology 2010; 34: 171-183.
5. Okinaka S, Reese HH, Katsuki S, Ueki K, Ku-roiwa Y, Araki S, Shiraki H, Kurland LT: The prevalence of multiple sclerosis and other neurological diseases in Japan. Acta Neurol Scand 1966; 47(s uppl 19): 68-76.
6. Eaton WW, Rose NR, Kalaydjian A, Peder-son MG, Mortensen PB: Epidemiology of autoimmune diseases in Denmark. J Autoim-mun 2007; 29: 1-9. (Pubitemid 47016917)
7. Garland H, Clark ANG: Myasthenia gravis, a personal study of 60 cases. BMJ 1956; 1: 1259-1262.
8. Aragones JM, Bolibar I, Bonfill X, Bufill E, Mummany A, Alonso F, Illa I: Myasthenia gravis: a higher than expected incidence in the elderly. Neurology 2003; 60:1024-1026. (Pubitemid 36355833)
9. Thanvi BR, Lo TCN: Update on myasthenia gravis. Postgrad Med J 2004; 80:690-700. (Pubitemid 39627099)
10. Matsuda M, Dohi-Iijima N, Nakamura A, Sekijima Y, Morita H, Matsuzawa S, Sato S, Yahikozawa H, Tabata K, Yanagawa S, Ikeda S: Increase in incidence of elderly-onset pat ient s w it h mya st hen ia g rav is i n Naga no Prefecture, Japan. Intern Med 2005; 44: 572-577.
11. Vincent A, Clover L, Buckley C, Evans JG, Rothwell PM, UK Myasthenia Gravis Survey: Ev idence of underdiag nosis of myasthe-nia gravis in older people. J Neurol Neuro-surg Psychiatry 2003; 74: 1105-1108.
12. Somnier FE: Increasing incidence of late onset anti-AChR antibody-seropositive myas-thenia gravis. Neurology 2005; 65:928-930. (Pubitemid 41362144)
13. Casetta L, Groppo E, De Gennaro R, Cesnik E, Piccolo L, Volpato S, Gra n ieri E: Mya sthe-nia gravis: a changing pattern of incidence. J Neurol 2010; 257:2015-2019.
14. Lovaste MG, Ferrari G: Epidemiology of my-asthenia gravis in the province of Trento (Northern Italy). Neuroepidemiology 1992; 11:135-142.
15. Grob D, Brunner NG, Namba T: The natural course of myasthenia gravis and effect of therapeutic measures. Ann NY Acad Sci 1981; 377: 652-669. (Pubitemid 12151750)
16. Phillips LH, Torner JC: Epidemiologic evidence for a changing natural history of my-asthenia gravis. Neurology 1996; 47:1233-1238. (Pubitemid 26374892)
17. Grob D, Brunner N, Namba T, Pagala M: Lifetime course of myasthenia gravis. Muscle Nerve 2008; 37: 141-149. (Pubitemid 351214160)
18. Heldal AT, Owe JF, Gilhus NE, Romi F: Sero-positive myasthenia gravis: a nationwide ep-idemiologic study. Neurology 20 09; 73: 150-151.
19. Poulas K, Tsibri E, Kokla A, Papanastasiou D, Tsouloufis T, Marinou M, Tsantili P, Pa-papetropoulos T, Tzartos SJ: Epidemiology of seropositive myasthenia gravis in Greece. J Neurol Neurosurg Psychiatry 2001; 71: 352-356. (Pubitemid 32772533)
20. Mantegazza R, Baggi F, Antozzi C, Confalo-nieri P, Morandi L, Bernasconi P, Andreetta F, Simoncini O, Ca mpa nella A, Beg hi E, Cor-nelio F: Myasthenia gravis (MG): epidemio-logical data and prognostic factors. Ann NY Acad Sci 2003; 998: 413-423. (Pubitemid 37194193)